Patent ID: 8895520

Claim:
A method for treating a human patient suffering from myeloid neoplasias, comprising administrating a therapeutically effective amount of a compound of formula (I): salt thereof, together with appropriate amounts of pharmaceutically acceptable diluents or carriers; wherein, R 2 , R 3 and R 5 are radicals independently selected from the group consisting of —H, —PO(OH) 2 , —PO(OH)—O—PO(OH) 2 , —PO(OH)—O—PO(OH)—O—PO(OH) 2 , —CO—R′ and —CO—OR′; R′ being a hydrocarbyl radical up to twelve carbon atoms, which may be an aliphatic substituent selected from alkyl, alkenyl, and alkynyl groups and groups which have a mixture of saturated and unsaturated bonds, alicyclic, aryl, and a combination thereof; wherein R′ may be a radical selected from a straight-chain, a branched-chain, a cyclic moiety, and a combination thereof; R′ may have one or more hydrogen atoms substituted for by one or more halogen atoms, and/or by one or more (C 1 -C 4 )-alkyl groups; R′ may have one or more CH 2 groups substituted for by one or more NH, O and/or S groups; and R′ may have one or more CH groups substituted by one or more N atoms.